Cargando…

Molecular characterization of Cryptosporidium isolates from humans in Ontario, Canada

BACKGROUND: Cryptosporidiosis is a gastrointestinal disease with global distribution. It has been a reportable disease in Canada since 2000; however, routine molecular surveillance is not conducted. Therefore, sources of contamination are unknown. The aim of this project was to identify species and...

Descripción completa

Detalles Bibliográficos
Autores principales: Guy, Rebecca A., Yanta, Christine A., Muchaal, Pia K., Rankin, Marisa A., Thivierge, Karine, Lau, Rachel, Boggild, Andrea K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821412/
https://www.ncbi.nlm.nih.gov/pubmed/33482898
http://dx.doi.org/10.1186/s13071-020-04546-9
_version_ 1783639418510245888
author Guy, Rebecca A.
Yanta, Christine A.
Muchaal, Pia K.
Rankin, Marisa A.
Thivierge, Karine
Lau, Rachel
Boggild, Andrea K.
author_facet Guy, Rebecca A.
Yanta, Christine A.
Muchaal, Pia K.
Rankin, Marisa A.
Thivierge, Karine
Lau, Rachel
Boggild, Andrea K.
author_sort Guy, Rebecca A.
collection PubMed
description BACKGROUND: Cryptosporidiosis is a gastrointestinal disease with global distribution. It has been a reportable disease in Canada since 2000; however, routine molecular surveillance is not conducted. Therefore, sources of contamination are unknown. The aim of this project was to identify species and subtypes of Cryptosporidium in clinical cases from Ontario, the largest province in Canada, representing one third of the Canadian population, in order to understand transmission patterns. METHODS: A total of 169 frozen, banked, unpreserved stool specimens that were microscopy positive for Cryptosporidium over the period 2008–2017 were characterized using molecular tools. A subset of the 169 specimens were replicate samples from individual cases. DNA was extracted directly from the stool and nested PCR followed by Sanger sequencing was conducted targeting the small subunit ribosomal RNA (SSU) and glycoprotein 60 (gp60) genes. RESULTS: Molecular typing data and limited demographic data were obtained for 129 cases of cryptosporidiosis. Of these cases, 91 (70.5 %) were due to Cryptosporidium parvum and 24 (18.6%) were due to Cryptosporidium hominis. Mixed infections of C. parvum and C. hominis occurred in four (3.1%) cases. Five other species observed were Cryptosporidium ubiquitum (n = 5), Cryptosporidium felis (n = 2), Cryptosporidium meleagridis (n = 1), Cryptosporidium cuniculus (n = 1) and Cryptosporidium muris (n = 1). Subtyping the gp60 gene revealed 5 allelic families and 17 subtypes of C. hominis and 3 allelic families and 17 subtypes of C. parvum. The most frequent subtype of C. hominis was IbA10G2 (22.3%) and of C. parvum was IIaA15G2R1 (62.4%). CONCLUSIONS: The majority of isolates in this study were C. parvum, supporting the notion that zoonotic transmission is the main route of cryptosporidiosis transmission in Ontario. Nonetheless, the observation of C. hominis in about a quarter of cases suggests that anthroponotic transmission is also an important contributor to cryptosporidiosis pathogenesis in Ontario. [Image: see text]
format Online
Article
Text
id pubmed-7821412
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78214122021-01-22 Molecular characterization of Cryptosporidium isolates from humans in Ontario, Canada Guy, Rebecca A. Yanta, Christine A. Muchaal, Pia K. Rankin, Marisa A. Thivierge, Karine Lau, Rachel Boggild, Andrea K. Parasit Vectors Research BACKGROUND: Cryptosporidiosis is a gastrointestinal disease with global distribution. It has been a reportable disease in Canada since 2000; however, routine molecular surveillance is not conducted. Therefore, sources of contamination are unknown. The aim of this project was to identify species and subtypes of Cryptosporidium in clinical cases from Ontario, the largest province in Canada, representing one third of the Canadian population, in order to understand transmission patterns. METHODS: A total of 169 frozen, banked, unpreserved stool specimens that were microscopy positive for Cryptosporidium over the period 2008–2017 were characterized using molecular tools. A subset of the 169 specimens were replicate samples from individual cases. DNA was extracted directly from the stool and nested PCR followed by Sanger sequencing was conducted targeting the small subunit ribosomal RNA (SSU) and glycoprotein 60 (gp60) genes. RESULTS: Molecular typing data and limited demographic data were obtained for 129 cases of cryptosporidiosis. Of these cases, 91 (70.5 %) were due to Cryptosporidium parvum and 24 (18.6%) were due to Cryptosporidium hominis. Mixed infections of C. parvum and C. hominis occurred in four (3.1%) cases. Five other species observed were Cryptosporidium ubiquitum (n = 5), Cryptosporidium felis (n = 2), Cryptosporidium meleagridis (n = 1), Cryptosporidium cuniculus (n = 1) and Cryptosporidium muris (n = 1). Subtyping the gp60 gene revealed 5 allelic families and 17 subtypes of C. hominis and 3 allelic families and 17 subtypes of C. parvum. The most frequent subtype of C. hominis was IbA10G2 (22.3%) and of C. parvum was IIaA15G2R1 (62.4%). CONCLUSIONS: The majority of isolates in this study were C. parvum, supporting the notion that zoonotic transmission is the main route of cryptosporidiosis transmission in Ontario. Nonetheless, the observation of C. hominis in about a quarter of cases suggests that anthroponotic transmission is also an important contributor to cryptosporidiosis pathogenesis in Ontario. [Image: see text] BioMed Central 2021-01-22 /pmc/articles/PMC7821412/ /pubmed/33482898 http://dx.doi.org/10.1186/s13071-020-04546-9 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Guy, Rebecca A.
Yanta, Christine A.
Muchaal, Pia K.
Rankin, Marisa A.
Thivierge, Karine
Lau, Rachel
Boggild, Andrea K.
Molecular characterization of Cryptosporidium isolates from humans in Ontario, Canada
title Molecular characterization of Cryptosporidium isolates from humans in Ontario, Canada
title_full Molecular characterization of Cryptosporidium isolates from humans in Ontario, Canada
title_fullStr Molecular characterization of Cryptosporidium isolates from humans in Ontario, Canada
title_full_unstemmed Molecular characterization of Cryptosporidium isolates from humans in Ontario, Canada
title_short Molecular characterization of Cryptosporidium isolates from humans in Ontario, Canada
title_sort molecular characterization of cryptosporidium isolates from humans in ontario, canada
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821412/
https://www.ncbi.nlm.nih.gov/pubmed/33482898
http://dx.doi.org/10.1186/s13071-020-04546-9
work_keys_str_mv AT guyrebeccaa molecularcharacterizationofcryptosporidiumisolatesfromhumansinontariocanada
AT yantachristinea molecularcharacterizationofcryptosporidiumisolatesfromhumansinontariocanada
AT muchaalpiak molecularcharacterizationofcryptosporidiumisolatesfromhumansinontariocanada
AT rankinmarisaa molecularcharacterizationofcryptosporidiumisolatesfromhumansinontariocanada
AT thiviergekarine molecularcharacterizationofcryptosporidiumisolatesfromhumansinontariocanada
AT laurachel molecularcharacterizationofcryptosporidiumisolatesfromhumansinontariocanada
AT boggildandreak molecularcharacterizationofcryptosporidiumisolatesfromhumansinontariocanada